Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2020 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 1,866 |
| TOTAL | $1,866 |
| Non-Current Assets | |
| Intangibles | 46 |
| TOTAL | $46 |
| Total Assets | $1,912 |
| Liabilities | |
| Current Liabilities | |
| TOTAL | $48 |
| Non-Current Liabilities | |
| TOTAL | $0 |
| Total Liabilities | $48 |
| Shareholders' Equity | |
| Common Shares | 2,397 |
| Retained earnings | -673 |
| Other shareholders' equity | 140 |
| TOTAL | $1,864 |
| Total Liabilities And Equity | $1,912 |